| NCT Number | NCT07048353 |
| Lead Sponsor | Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
Collaborators: Tongji Hospital Affiliated to Tongji Medical College of HUST, Shanxi Bethune Hospital, Wuhan Central Hospital, Yichang Central People's Hospital, First Affiliated Hospital of Guangxi Medical University |
| Conditions | Lymphoma, B Cell Lymphoma, CD30+ Peripheral T-cell Lymphoma |
| Enrollment | 15 participants |
| Start Date | 2025-07-28 |
| Primary Completion | 2029-07-28 (estimated) |
| Study Completion | 2029-07-28 (estimated) |
| Updated on ClinicalTrials.gov | 2025-07-02 |